Park Avenue Securities LLC Insulet Corp Transaction History

Park Avenue Securities LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	SELL	$186.4 - $279.02 $147,815 - $221,262	-793 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$194.8 - $275.7 $154,476 - $218,630	793 New	793 $211,000
Q4 2021 Apr 08, 2022	SELL	$255.32 - $318.29 $185,617 - $231,396	-727 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$260.36 - $307.27 $189,281 - $223,385	727 New	727 $207,000
Q4 2020 Jan 20, 2021	SELL	$215.97 - $265.89 $257,436 - $316,940	-1,192 Closed	0 $0
Q3 2020 Nov 03, 2020	BUY	$192.55 - $236.59 $17,907 - $22,002	93 Added 8.46%	1,192 $282,000
Q2 2020 Jul 30, 2020	BUY	$159.17 - $224.73 $174,927 - $246,978	1,099 New	1,099 $213,000

687

62.7M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.7B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Park Avenue Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Park Avenue Securities LLC with notifications on news.